120
Participants
Start Date
February 15, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2027
Fish Oil
"Omegaven® is a 10% fish oil emulsion with a high percentage of long-chain n-3 fatty acids - mainly eicosapentaenoic acid and docosahexaenoic acid. It optimises the fatty acid pattern in parenteral nutrition and is a source of polyunsaturated n-3 fatty acids as cell membrane components and precursors for eicosanoids.~Omegaven® is manufactured by Fresenius-Kabi, Germany and is available in 100 mL bottles for study purpose.~Each 100 mL of Omegaven® contains 10 g of fish oil (0.1 g/mL).~Timeframe: Day -1: 0.20 g fish oil/kg BW/d (the treatment should be started 24 to 3 h before surgery, can be given as 3-6 hours infusion); intraoperative day 0: no dose; postoperative day 0: 0.20 g fish oil/kg BW/d; postoperative days 1 to max. 7): 0.20 g fish oil/kg BW/d"
Intravenous 0.9% Sodium Chloride
Intravenous 0.9% Sodium Chloride (volume 2 mL/kg BW/d) provided at the same timepoints as the intervention.
NOT_YET_RECRUITING
University Hospital Augsburg, Augsburg
RECRUITING
Charité Universitätsmedizin Berlin, Berlin
RECRUITING
University of Bonn, Bonn
RECRUITING
University Hospital Goettingen, Göttingen
RECRUITING
University Hospital Hamburg-Eppendorf, Hamburg
RECRUITING
University Medical Center Schleswig-Holstein, Kiel
RECRUITING
University Hospital Mainz, Mainz
RECRUITING
University Hospital Muenster, Münster
University Hospital, Bonn
OTHER
University Hospital Muenster
OTHER
University Hospital Goettingen
OTHER
University Hospital Schleswig-Holstein
OTHER
Charite University, Berlin, Germany
OTHER
Wuerzburg University Hospital
OTHER
Johannes Gutenberg University Mainz
OTHER
University Hospital Augsburg
OTHER
Universitätsklinikum Hamburg-Eppendorf
OTHER
GCP-Service International West GmbH
INDUSTRY